SCHOTT Plans To Build State-Of-The-Art High-Quality Pharmaceutical Glass Tubing Plant In China

Specifications:

Name:

SCHOTT Plans To Build State-Of-The-Art High-Quality Pharmaceutical Glass Tubing Plant In China

Location:

China

Company:

SCHOTT

Estimated Cost:

-

Source:

www.schott.com

Introduction:

The international technology group SCHOTT plans to build State-Of-The-Art greenfield pharmaceutical glass tubing plant in Jinyun, Zhejiang.

Features:

The new plant will enable SCHOTT to participate in the advancement of the Chinese pharmaceutical packaging industry. SCHOTT will invest 60 million Euros in the first phase to install a yearly capacity of up to 20.000 tons. The production is scheduled to start at the end of 2020.

The new plant will supply the Chinese domestic pharmaceutical packaging market to aid its development. “We believe that healthy people make for a thriving society,” comments Dr Patrick Markschläger, Executive Vice President of SCHOTT AG Business Unit Tubing. “SCHOTT has the experience, heritage and foresight to help make China’s vision “Healthy China 2030” become reality.”

The plant will manufacture FIOLAX® glass tubing, which is a 5.0 middle borosilicate glass. Hence, the manufacturing site will support the move away from the low borosilicate glass (so called 7.0 glass type) to the higher quality middle borosilicate glass (so called 5.0 glass type), which is already well established globally. Production will be based on SCHOTT’s unique perfeXion® process with 100% quality control of each individual tube and in accordance with the worldwide quality criteria of SCHOTT Tubing.